Antiplatelet Therapy clinical trials

Explore recruiting antiplatelet therapy clinical trials.

Recruiting antiplatelet therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Antiplatelet Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Short versus long antiplatelet therapy after TAVI

France

Phase II and Phase III (Integrated) EU CTIS Study details

Stopping or continuing platelet inhibitors after cryptogenic stroke at young age: STOP trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE

France

Therapeutic use (Phase IV) EU CTIS Study details

Randomized comparison of short versus 12 months prasugrel plus aspirin in patients with acute coronary syndromes treated with percutaneous coronary intervention and everolimus-eluting stents

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Ischemic and bleeding outcomes after angiolite stent implantation and an abbreviated dual antiplatelet therapy. A 2x2 factorial, all-comer, multicenter, randomized controlled trial: ANGIODAPT

Spain, Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PROTamine Application in patients underGOing tRAnScatheter aortic valve replacement (PROTAGORAS)

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Antiplatelet Therapy trials by city

Antiplatelet Therapy in Toronto Antiplatelet Therapy in Vancouver Antiplatelet Therapy in Montreal Antiplatelet Therapy in Calgary Antiplatelet Therapy in Edmonton Antiplatelet Therapy in Ottawa Antiplatelet Therapy in Winnipeg Antiplatelet Therapy in Quebec City Antiplatelet Therapy in Hamilton Antiplatelet Therapy in Kitchener Antiplatelet Therapy in London Antiplatelet Therapy in Halifax Antiplatelet Therapy in New York Antiplatelet Therapy in Los Angeles Antiplatelet Therapy in Chicago Antiplatelet Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease